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 Neurodegenerative gradient along the injured spinal cord after SCI 
 Neurodegenerative gradient predicts level of impairment after SCI 
 Quantitative MRI reveals demyelination as a key contributor to degenertation 
 
  
         
Azzarito 2 
 




, Maryam Seif, PhD
1





, and Patrick Freund, MD PhD
1,2,3,4 
1
Spinal Cord Injury Center Balgrist, University Hospital, Zurich, Switzerland 
2
Department of Neurophysics, Max Planck Institute for Human Cognitive and Brain Sciences, 
Leipzig, Germany 
3
Wellcome Trust Centre for Neuroimaging, UCL Institute of Neurology, London, United Kingdom 
4
 Department of Neurology, University Hospital Zurich, Zurich, Switzerland 
Running title:  spinal cord gradient predict recovery after SCI 
Correspondence to: 
Prof. Patrick Freund, Spinal Cord Injury Center, Balgrist University Hospital, Forchstrasse 
340, 8008 Zurich, Switzerland, E-mail: patrick.freund@balgrist.ch, Phone: +41 (0)44 386 37 
37, Fax: +41 (0)44 386 37 31 
Word count in total: 3081 - Abstract: 250 words, Introduction: 356 words, Discussion: 996 words, 
No. of Tables/figures: 2 table/ 5 figures, No. of References: 36 
Abbreviations:  
AIS = American Spinal Injury Association Impairment; APW= anterior-posterior width; ISNCSCI = 
International Standards for Neurological Classification of Spinal Cord Injury; LRW=left-right width;  
MPM = multi-parameter mapping; MT = magnetization transfer; p.u. = percentage unit; pSCI = 
paraplegics; SC = spinal cord; SCI = spinal cord injury ; SCIM = spinal cord independence measure; 
tSCI = tetraplegics; VBM = voxel based morphometry; VBQ = voxel based quantification.  
         
Azzarito 3 
 
Authors’ contact address  
Michela Azzarito: michela.azzarito@balgrist.ch, Spinal Cord Injury Center, Balgrist 
University Hospital, Forchstrasse 340, 8008 Zurich, Switzerland, Phone number: +41 44 510 
72 14 
Dr. Maryam Seif:  Maryam.Seif@balgrist.ch, Spinal Cord Injury Center, Balgrist University 
Hospital, Forchstrasse 340, 8008 Zurich, Switzerland, Phone number: +41 44 510 72 14 
Dr. Sreenath Kyathanahally: pruthvi.iyengar@gmail.com, Spinal Cord Injury Center, Balgrist 
University Hospital, Forchstrasse 340, 8008 Zurich, Switzerland, Phone number: +41 44 510 
72 14 
Prof. Dr. Armin Curt: armin.curt@balgrist.ch, Spinal Cord Injury Center, Balgrist University 
Hospital, Forchstrasse 340, 8008 Zurich, Switzerland Phone number: +41 44 510 3901 
Disclosure statement 
MSc Michela Azzarito reports no disclosures. Dr. Seif Maryam reports no disclosures. Dr. 
Sreenath Kyathanahally reports no disclosures. Prof. Armin Curt reports no disclosures. Prof. 
Patrick Freund reports no disclosures. 
 
  




Objective: To quantify neurodegenerative changes along the cervical spinal cord rostral to a 
spinal cord injury (SCI) by means of quantitative MRI (qMRI) and to determine its 
relationship with clinical impairment. 
Methods: Thirty chronic SCI patients (15 tetraplegics and 15 paraplegics) and 23 healthy 
controls underwent a high-resolution T1-weighted and myelin-sensitive magnetization 
transfer (MT) MRI. We assessed macro- and microstructural changes along the cervical cord 
from levels C1 to C4, calculating cross-sectional spinal cord area, its anterior-posterior and 
left-right width and myelin content (i.e. MT). Regression analysis determined associations 
between qMRI parameters and clinical impairment.  
Results: In SCI patients, cord area decreased by 2.67 mm
2
 (p=0.004) and left-right width 
decreased by 0.35 mm (p=0.002) per level in caudal direction when compared to the healthy 
controls. This gradient of neurodegeneration was greater in tetraplegic than paraplegics in the 
cord area (by 3.28 mm
2
, p=0.011), left-right width (by 0.36 mm, p=0.03), and MT (by 0.13%, 
p=0.04), but independant of lesion severity (p>0.05). Higher lesion level was associated with 
greater magnitudes of neurodegeneration. Greater loss in myelin content in the dorsal 
columns and spinothalamic tract was associated with worse light touch (p=0.016) and pin 
prick score (p=0.024), respectively.  
Conclusions: A gradient of neurodegeneration is evident in the high cervical cord remote 
from a SCI. Tract-specific associations with appropriate clinical outcomes highlight that 
remote neurodegenerative changes are clinically eloquent. Monitoring the neurodegenerative 
gradient could be used to track treatment effects of regenerative and neuroprotective agents, 
both in trials targeting cervical and thoracic SCI patients. 
Keywords: Spinal cord injury, MRI, Volumetric MRI, MT 




Traumatic spinal cord injury (SCI) leads most often to paralysis below the level of injury and 
functional recovery is limited (Ahuja et al., 2017). Based on the lesion level, SCI patients can 
be dichotomized into tetraplegics (tSCI) and paraplegics (pSCI) (Kirshblum et al., 2011). 
Evidence from experimental SCI have shown that axonal degeneration and demyelination of 
spinal pathways is greatest close to the injury and decreases with increasing distance 
(Bresnahan, 1978; Bresnahan et al., 1976; Freund et al., 2007; Grumbles and Thomas, 2017; 
Kalil and Schneider, 1975; Kerschensteiner et al., 2005). In human SCI, tissue-specific 
neurodegenerative changes have been quantified in the spinal cord either at the C2/C3 level 
(Freund et al., 2013, 2011; Huber et al., 2018; Lundell et al., 2011; Seif et al., 2018) or at the 
lumbar enlargement (David et al., 2019), but not along the spinal cord. Thus it is unknown 
whether a tract-specific neurodegenerative gradient exists (Bresnahan, 1978; Bresnahan et al., 
1976; Kalil and Schneider, 1975; Kerschensteiner et al., 2005) that could be quantified in-
vivo. This could for example facilitate monitoring effects of regenerative and neuroprotective 
treatments. However, a potential gradient of change could be influenced by the level of injury 
and the anatomical characteristics of the spinal level being affected by a lesion. Therefore, a 
lesion higher in the cervical cord will injure more axons that project through it (more 
neurodegeneration) than an identical lesion more caudal in the cord. Moreover, the 
descending motor tracts (i.e. corticospinal, rubrospinal tracts) located in the lateral funiculi 
and the ascending sensory pathways (i.e. fasciculus gracilis and cuneatus) located in the 
dorsal column undergo different types of degeneration. While the descending motor tracts 
undergo retrograde degeneration, which are greatest in the proximity of the injury (Bresnahan 
et al., 1976; Kalil and Schneider, 1975), the ascending tracts undergo Wallerian degeneration 
as their axon stumps are disconnected from their parental neuron.  
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Here we use the spinal cord toolbox (SCT) (De Leener et al., 2017) to analyse volumetric T1-
weigthed MRI data (Tardif et al., 2009) and myelin-sensitive magnetisation transfer 
saturation (MT) maps (Helms et al., 2008) along the cervical cord from C1 to C4 to assess 
changes to the cords’ morphometry (Huber et al., 2018) and  its myelin content (Schmierer et 
al., 2004), respectively. Based on the literature (Freund et al., 2019), we hypothesized that (i) 
a neurodegenerative gradient will be present in SCI patients with more atrophy closer to the 
injury epicentre (i.e. changes at level C4>C3>C2>C1); (ii) these atrophic changes are more 
pronounced in tetraplegics when compared to paraplegics given the proximity of this 
investigated region to the site of injury; (iii) the pathophysiological underpinning of the 
atrophy is related to demyelination by means of myelin-sensitive MT and; (iv) the magnitude 
of neurodegeneration is associated with clinical impairment. 
Materials and methods 
Participants and study design 
Thirty patients with traumatic SCI, 15 tetraplegic (age: mean 42.61 ± SD 17.64 years, 1 
female), 15 paraplegic (age: mean 46.73 ± SD 16.09 years, 2 females), and 23 healthy 
subjects (age= mean 36.87 ± SD 11.76 years, 10 females) were recruited at the University 
Hospital Balgrist between August 2011 and May 2015. The exclusion criteria for SCI patients 
were: time since injury <2 months, pregnancy, head or brain lesions associated with spinal 
cord injury, pre-existing neurological and medical disorders leading to functional 
impairments, mental disorder, or contraindications to MRI. Note that one of the paraplegics 
patients recovered from AIS score D to E during this study (see Table 1). The exclusion 
criteria for healthy subjects were: any neurological or mental disorder or pregnancy. 
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Standard protocol approvals, registrations, and patient consents 
The study was approved by the local ethics committee of Zurich the ‘Kantonale 
Ethikkommission Zurich’ (EK-2010-0271), and the study protocols were in accordance with 
the Declaration of Helsinki. All subjects provided written informed consent prior to 
enrolment.  
Clinical assessments 
SCI patients underwent a comprehensive clinical protocol including the International 
Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) (Kirshblum et al., 
2011) for motor, light touch, and pin prick score; the Spinal Cord Independence Measure 
(SCIM) (Catz et al., 2007); and the Graded Redefined Assessment of Strength, Sensibility, 
and Prehension (GRASSP) particularly in tetraplegics patients (Kalsi-Ryan et al., 
2012)(Table 1).   
Image acquisition 
Participants underwent a T1-weighted 3D Magnetization Prepared Rapid Acquisition 
Gradient-Echo (MPRAGE) scan (whole-brain including the cervical cord down to C4 level) 
on a 3T MRI scanner (Magnetom Skyra
Fit
 and Verio, Siemens Healthcare, Erlangen, 
Germany). The system was equipped with a 16-channel radiofrequency (RF) receive head 
and neck coil and RF body transmit coil. The MRI parameters used in T1-weighted scan were 
as follows: field of view (FOV) of 224 x 256 mm
2
, matrix size of 224 x 256, isotropic 
resolution of 1 mm
3
, repetition time (TR)=2420 ms, echo time (TE)= 4.18 ms, flip angle(α )= 
9°, inversion time = 960 ms, and readout bandwith of 150 Hz per pixel.  
To assess microstructural changes (myelination) associated with quantitative MR parameters, 
a whole-brain multi-parameter mapping (MPM) protocol (Callaghan et al., 2015; Helms et 
al., 2009, 2008; Weiskopf et al., 2013, 2011) was performed using a 3D multi-echo fast low-
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angle shot (FLASH) gradient-echo sequence. MPM protocol is designed to provide MR 
parameter measures of longitudinal relaxation rate (R1=1/T1), effective proton density (PD*), 
magnetization transfer saturation (MT) and effective transverse relaxation rate (R2*=1/T2*). 
MRI scans cover the whole brain and cervical cord down to the C4 level with 1 mm isotropic 
resolution, FOV=240×256 mm
2
 and matrix-size=5240×256, with 176 partitions. Total scan 
time was 23 minutes applying parallel imaging in the phase-encoding direction using a 
generalized auto-calibration partially parallel acquisition algorithm (GRAPPA) factor 2×2 
and readout bandwidth of 480 Hz/pixel. MPM protocol consists of three different MRI 
weighted contrasts, each acquired using a different TR and flip angle (α):(1) T1-weighted 
scan: 25 ms / 23°, (2) PD-weighted scan: 25 ms / 4°, and (3) MT-weighted  scan: 37 ms / 9° 
with off-resonance RF pulse prior to excitation. Echoes were acquired at six equidistant times 
of echo (TE) from 2.46 ms to 17.22 ms for all volumes and an additional echo time at 19.68 
ms for PD-weighted and T1-weighted scans. 
MRI Data processing  
MT-weighted, PD-weighted, and T1-weighted images acquired from MPM protocol were 
used to compute quantitative maps of MT, R1 and R2* using SPM12 (University College 
London, London, UK). The quality at cervical level C4 for R1 and R2* maps, after visual 
inspection, was insufficient and therefore could not be reliably analysed. 
T1-weighted images (MPRAGE) and MT maps were analysed using spinal cord toolbox 
(SCT) (De Leener et al., 2017) following the automatic pipeline to register, warp, and extract 
morphometric and microstructural parameters. The pipeline included automatic spinal cord 
segmentation followed by visual inspection and manual correction of the generated masks if 
necessary (in FSL; https://fsl.fmrib.ox.ac.uk/). Next, the generated spinal cord mask was 
registered to the MNI-Poly-AMU template (De Leener et al., 2018) using a combination of 
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affine and nonlinear registrations, and the reverse deformation field (template to subject) was 
applied to the white matter (WM) and gray matter (GM) atlases, projecting them into the 
subject space. Finally, morphometric and microstructural parameters were extracted 
automatically from the spinal cord at each level (from cervical level C1 down to cervical 
level C4). Morphometric SC parameters consisting of anterior-posterior width (APW), left-
right width (LRW) and spinal cord cross-sectional area (SCA) were extracted from the 
segmented T1-weighted. Myelin sensitive MT values were extracted from the segmented MT 
map. Figure 1 demonstrates the processing pipeline. Voxel-wise analysis was performed on 
the MT maps in SPM12 after warping into template space (PAM50) and applying an 
anisotropic smoothing along the main axis (gaussian kernel with sigma 3 mm in SCT). 
Statistical analysis 
 To investigate the difference between SCI patients and healthy controls in spinal cord 
morphometry (i.e. cord area, APW and LRW) and microstructure (i.e. MT), a linear mixed 
effect model across the cervical segments (from C1 to C4) and across groups (healthy 
controls, both patients groups combined, as well as pSCI and tSCI separately) was conducted 
in Stata (Stata Corp 13.0, College Station, TX). Post-hoc pairwise comparisons were 
performed, adjusted for multiple comparisons using Bonferroni correction. To assess lesion 
completeness effects (AIS scores), spinal cord parameters at all spinal cord levels were 
compared between AIS A/B and AIS C/D in tetraplegics and paraplegics patients using a 2-
sample t-test (1-tailed, unequal variances, α = 0.05). 
The correlation between lesion level and spinal cord MRI (using the mean value along the 
levels C2 to C4) measures was assessed using an ordinal logit regression, entering an 
indicator of the lesion level, defined on the basis of the neurological lesion level, as response 
variable. Furthermore, multiple linear regressions were used to assess the correlation between 
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qMRI parameters (using the mean value along the levels C2 to C4) and sensorimotor 
outcome measures (light touch, pin-prick, and SCIM scores). In order to determine if these 
associations were different in tSCI and pSCI, subject type indicator and type*predictor 
interaction terms were added; however there was no evidence that associations were different 
in tSCI and pSCI and therefore the combined group was used in these analyses. 
MT maps in PAM50 space were additionally analysed using general linear models (GML). 
Uncorrected voxel threshold of p=0.001 was initially considered, and to account for multiple 
comparisons, family wise error correction (FWE) based on Gaussian random field theory, 
was applied. Only clusters surviving a corrected cluster threshold of p=0.05 were reported 
(Friston et al., 1994). ANOVA tests were used in each voxel of interest to investigate spinal 
cord changes in SCI patients compared to healthy controls; and tSCI compared to pSCI. 
Additionally, associations between myelin sensitive microstructural changes and functional 
recovery (LEMS, light-touch, pin prick and SCIM scores) were investigated. All Statistical 
tests were corrected for age as a cofactor of no interest and only results with a significant 
threshold of p<0.05 were reported. 
Data availability 
As the data are patient sensitive, the data will be made only available on request and fully 
anonymized.  
Results 
Demographic, clinical, and radiologic characteristics 
There was no significant differences in age (ANOVA, f = 2.08 p = 0.135) or in sex (chi-
square, p = 0.435) across the three groups (controls, tSCI and pSCI). tSCI patients were 
scanned on average 2.5 ± SD 3.9 years following the injury and were classified according to 
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the American Spinal Injury Association Impairment Scale (AIS) as 6  AIS A, 2 AIS B, 1 AIS 
C and 6 AIS D. pSCI patients were scanned on average 3.6 ± 6.8 years following the injury 
and were classified as  8 AIS A, 4 AIS  B, 2 AIS D and 1 AIS E. 
Neurodegenerative gradient  
Cross-sectional cord area and its APW were decreased across all cervical cord levels in SCI 
patients (tSCI+pSCI) when compared to healthy controls (p<0.05), while LRW showed 
decreases at levels C2, C3 and C4 (p<0.05) (figure 2A-C, table 2). The magnitude of spinal 
cord area and shape changes in all SCI patients (tSCI+pSCI) was greater at lower cervical 
levels (i.e. closer to the lesion level, C4>C3>C2>C1), defining a neurodegenerative gradient. 
Cord area decreased by 2.67 mm
2
 per cervical cord level in the caudal direction [95% CI -
4.48 to -0.86] (p=0.004) and LRW decreased by 0.35 mm [95% CI -0.57 to -0.13] (p=0.002) 
APW presented a negative gradient in caudal direction in all SCI patients (tSCI+pSCI) (APW 
decreased by 0.31 mm per cord level [95% CI -0.33 to -0.16] (p<0.001)) and healthy controls 
(APW decreased by 0.24 mm per cord level [95% CI -0.39 to -0.24] (p<0.001)), without a 
significant difference in the rate of change of the gradient (p=0.197).  
In a within patient analysis (tSCI vs. pSCI), cord area decreased by 3.28 mm
2 
per cord level 
more in tSCI patients than in pSCI in the caudal direction, p=0.011, [95% CI -5.99 to -0.57] 
(figure 3A). In tSCI patients, the APW showed a trend decrease when compared to pSCI 
patients (tSCI decreased by 0.15 mm more than in pSCI in the caudal direction, p=0.07 [95% 
CI -0.31 to 0.0084]) (figure 3B); whereas LRW decreased by 0.36 mm more in tSCI than in 
pSCI in the caudal direction, p=0.03 [95% CI -0.70 to -0.03]) (figure 3C). Comparing MRI 
metrics of AIS A/B vs AIS C/D in tSCI patients vs. pSCI patients across all spinal cord levels 
did not show significant differences (p>0.05). 




In SCI patients (tSCI+pSCI), myelin-sensitive MT was decreased across all cervical levels (z-
score=5.85, x=3.5, y=2.0, z=195.5, p<0.001, CE=2752) when compared to healthy controls 
(figure 2D, 3E; table 2).  
In a within patient group analysis (tSCI vs. pSCI), the decrease in myelin-sensitive MT in the 
cord was greater in tSCI patients at level C1 (z-score=5.04, x=0, y=-0.5, z=195, p<0.001, CE 
= 1036) and C4 (z-score = 5.41, x = -0.5, y=-3, z=201, p<0.001, cluster extent (CE) = 2621) 
(figure 3F) when compared to pSCI. Mean MT in the cord decreased by 0.13% per cord level 
in tSCI patients when compared to pSCI in the caudal direction, p=0.04 [95% CI -0.26 to -
0.004] (figure 3D). 
Associations between structural changes, lesion level and clinical outcome 
In SCI patients (tSCI+pSCI), lesion level was associated with smaller mean cross-sectional 
cord area (p<0.001, r
2
=0.146, [95% Confidence interval (CI): 0.081-0.243]), mean APW 
(p<0.001, r
2
=0.134; [CI: 1.011-3.228]), mean LRW (p=0.003, r2=0.085; [CI: 0.369-1.792]), 
and mean cord MT (p<0.001, r
2
=0.139; [CI: 1.923-6.083]) (figure 4).  
In SCI patients (tSCI+pSCI), better pin prick score was associated with greater mean cord 
area (p=0.016, r2=0.416; [CI: 0.201-1.826]) and APW (p=0.007, r
2
=0.450; [CI: 4.869-
27.646]). In SCI patients (tSCI+pSCI), higher light touch score was associated with greater 
mean APW (p= 0.033, r
2
=0.389; [CI: 1.069- 23.248]) and higher SCIM score was associated 
with greater mean cord area (p=0.041, r
2
=0.215; [CI: 0.042-1.805]) and mean APW 
(p=0.035, r
2
=0.223; [CI: 1.041-25.902]). In SCI patients (tSCI+pSCI), greater mean MT in 
the dorsal column was associated with greater light touch score (z-score=4.86, x=2, y=-3, 
z=143, p=0.016, CE=1166) (figure 5A). In SCI patients (tSCI+pSCI), greater mean MT in the 
dorsal columns (z-score=5.07, x=-1, y=-3, z=200.5, p<0.001, CE=3830) and spinothalamic 
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tract (z-score=4.85, x=-3, y=2, z=175, p=0.024, CE=1048) was associated with better pin 
prick score (figure 5B). In SCI patients (tSCI+pSCI), greater mean MT in the dorsal column 
(z-score=4.39, x=-1, y=-2.5, z=187, p<0.001, CE=3576) and spinothalamic tract (z-
score=4.06, x=-3, y=2.5, z=173, p=0.045, CE=839) was associated with better SCIM score 
(figure 5C). Spinal cord MRI indices were not associated with clinical scores of motor 
function (p>0.05). 
Discussion 
This study shows a lesion level dependent change in the magnitude of neurodegeneration 
across the high cervical cord, with greater atrophic and myelin-sensitive MT reductions 
occurring in the proximity of the injury. These changes are less pronounced with increasing 
distance from the injury showing a gradient of neurodegeneration. In addition, changes in the 
spinal cord macro- and microstructure were associated with tract-specific clinical outcomes. 
Tracking of a neurodegenerative gradient holds potential as a new neuroimaging biomarker to 
monitor treatment effects of regenerative and neuroprotective agents in interventional trials. 
Characteristics of the neurodegenerative gradient  
This is the first study to reveal a neurodegenerative gradient over several cervical segments 
(from C1 to C4) remote from a spinal cord injury in chronic tetraplegic and paraplegic 
patients. The extent of neurodegeneration was greatest in the proximity of the lesion and 
declining with increasing distance from the injury. Interestingly, only changes in the cords’ 
left-right direction showed a neurodegenerative gradient while the observed decrease in the 
anterior-posterior direction was equally decreased across all cervical levels. Changes in the 
cords’ LRW (Lundell, 2011) have been associated with retrograde degeneration of the 
corticospinal tract (Lemon, 2008); whereas changes in the APW (Grabher et al., 2015; 
Jutzeler et al., 2016; Lundell et al., 2011) have been associated with anterograde degeneration 
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(i.e. Wallerian degeneration) in the posterior columns (Daniel and Strich, 1969). The lack of a 
neurodegenerative gradient within the dorsal columns – despite showing significant 
neurodegeneration –  suggests that the magnitude of anterograde axonal degeneration in the 
posterior columns (i.e. Wallerian degeneration) (Daniel and Strich, 1969) is equally 
distributed across cervical levels (i.e. no gradient); while degeneration of the CST (captured 
by the LRW gradient) is greatest in the proximity of the injury epicentre and declines with 
increasing distance (Kalil and Schneider, 1975; Kerschensteiner et al., 2005). This gradient of 
neurodegenerative could be in part explained by the anatomical organization of the cord 
where an increasing number of axons enter or exit the cord from the cervical cord down to 
the thoracic cord. Therefore lesions at higher anatomical levels (rostrally) will injure more 
axons that project through it (more neurodegeneration) than an identical lesion more distant 
in the cord (caudally). In support of this point, higher lesion level has been directly associated 
with the magnitude of neurodegeneration (Jutzeler et al., 2016). However, the fact that 
significant neurodegenerative changes were detected in both tetraplegic and paraplegic 
patients in the high cervical cord independent of lesion severity suggests that a 
neurodegenerative gradient occurs above a SCI at any lesion level. It remains to be revealed 
whether a similar neurodegenerative gradient exists caudally to a SCI. This is of particular 
importance for repair studies which would aim to reduce the amount of degeneration in the 
caudal proximity of the injury via regenerating fibres. The fact that the lumbar cord 
undergoes neurodegenerative changes after a cervical SCI (David et al., 2019) speaks 
however for a neurodegenerative gradient occurring also below the level of injury. 
Pathophysiological changes 
By means of myelin-sensitive MT (Helms et al., 2008) we were able to disentangle one of the 
underlying pathophysiological mechanisms contributing to cord atrophy. Previous studies 
showed a centrifugal pattern of axonal degeneration starting from the lesion site (Bresnahan, 
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1978; Bresnahan et al., 1976; Kalil and Schneider, 1975; Kerschensteiner et al., 2005) with a 
gradual myelin loss propagation (Buss et al., 2005, 2004). This demyelination was shown to 
be a slow and continuous process covering more years after injury (Buss et al., 2005, 2004). 
Specifically, myelin proteins were still detectable 3 years after injury in the degenerating 
fibre tracts, long after the disappearance of the corresponding axons (Beirowski et al., 2005; 
Buss et al., 2004). As expected, the magnitude of the neurodegenerative gradient in the C1-
C4 region was greater in tSCI patients when compared to pSCI, given the proximity of this 
investigated region to the site of injury. Therefore, myelin-sensitive MT, once proven in 
longitudinal studies, could be explored as a biomarker to monitor tract-specific myelin 
changes. 
Associations between structural changes and clinical outcome 
We found tract-specific associations with appropriate clinical outcomes. For instance, greater 
myelin-sensitive MT decreases in the dorsal column were directly linked to worse light touch 
scores, while a greater decrease of myelin-sensitive MT was associated with reduced pin 
prick and SCIM scores in both, dorsal column and spinothalamic tracts.  In agreement with 
previous reports, greater changes in the cords’ APW were related to worse pin prick and light 
touch scores (Grabher et al., 2015; Lundell et al., 2011). The concurrent associations between 
sensory outcomes with atrophy in APW and functional independence measures with 
decreased myelin-sensitive MT in the ascending pathways, supports the notion that 
demyelination is a critical factor in the pathobiology of human SCI (Buss et al., 2005, 2004). 
Therefore, both APW and MT readouts hold promise as biomarkers for assessing changes of 
sensory function in traumatic SCI patients.  




This study has some limitations. Patients were on average 8 years older than healthy controls. 
However, all statistical analyses were corrected for the linear effect of age. The automatic 
segmentation tool used to process the data required manual editing. MPM protocols 
(Weiskopf et al., 2013) provide maps sensitive to myelin (R1 and MT) and iron content 
(R2*). However, the quality of R1 and R2* maps at lower cervical cord levels was poor and 
could not be used for the analysis. Moreover, the interpretation of myelin-sensitive MT maps 
should be handled with caution as MT is an indirect marker for myelin and cannot directly 
describe underlying biological changes at the microscopic level. Nevertheless, 
histopathological studies have shown association between changes in MT and myelination 
(Schmierer et al., 2004; Turati et al., 2015).  
Conclusion 
In conclusion, this study shows that the magnitude of neurodegeneration decreases along the 
cervical SC. In particular, the extent of neurodegeneration was more pronounced closer to the 
injury and directly correlated with the level of the injury and clinical impairments. Tracking 
remote cord pathology over several spinal segments is clinically eloquent. Future longitudinal 
study will have to test the potential of the MRI based neurodegenerative gradient measures 
whether these are sensitive to change over time and can differentiate between tSCI and pSCI 
patients. If proven, then MRI based neurodegenerative gradient measures could be used to 
monitor treatment effects of regenerative and neuroprotective agents.  
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Figure 1: Pre-processing steps for the analysis of MRI scans.  
Image registration pipeline for T1-weighted MRI from a healthy subject to PAM50 template 
using the spinal cord toolbox. The original T1-weighted image (A) was segmented using deep 
segmentation(Perone et al., 2018) and the spinal cord mask was generated (B). Next, the 
template (MNI-poly T1w) was warped into subject space (C) and the T1-weighted image was 
warped into template space (straightened) (D). Vertebral levels were automatically labelled 
(E) and GM (yellow) and WM (blue) probabilistic atlases were warped back to native space 
(sagittal view in F)(De Leener et al., 2017). Segmented SC from C1 level down to C4 is 
presented in column 1. 




Figure 2: Spinal cord parameters from level C1 to C4.  
Morphometric and myelin-sensitive magnetization transfer parameters (coloured dots) at each 
individual cervical cord level (from C1 to C4) are shown (controls (blue), SCI (tSCI + pSCI, 
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green), paraplegics (pSCI, black) and tetraplegics (tSCI, red)). Spinal cord parameters 
include: cross-section spinal cord area in A, its anterior posterior width (APW) in B, its left 
right width (LRW) in C and mean cord MT in D. Boxplots show the median (central mark), 
the 25th and 75th percentiles (bottom and top edges, respectively). The * symbol indicates 
significant differences (p<0.05, family-wise corrected) between the connected groups. 
 
 
Figure 3: Neurodegeneration along the spinal cord.  
Spinal cord area (A),  anterior posterior width (B),  left right width (C) and myelin-sensitive 
magnetization transfer MT (D) parameters (coloured dots) along the cervical cord (from C1 
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to C4) in controls (blue), paraplegics (pSCI, black) and tetraplegics (tSCI, red). The light-
coloured lines are connecting subject specific data; bold lines represent changes along the 
cervical cord axis for each group. Changes in myelin-sensitive magnetization transfer (MT) 
from the voxel-wise analysis in template space (PAM50(De Leener et al., 2018)) are shown 
in E and F. Overlay of statistical parametric maps (uncorrected p<0.01, for illustrative 
purposes only) shows decreased myelin-sensitive MT in SCI patients compared to controls 
(E); and tetraplegic compared to paraplegic patients (F). The colour bar indicates the t score.  
 
 
Figure 4: Correlations between lesion level and spinal cord parameters.  
On the y-axis the lesion level is represented defined on the basis of the neurological lesion 
level; on the x-axis the mean value of the individual MRI indices over cervical levels (from 
C1 to C4) in tSCI (red) and pSCI (blue) patients.  





Figure 5: Correlations between clinical measures and spinal cord parameters. 
Correlations between myelin-sensitive magnetization transfer (MT) and light touch score (A); 
pin prick score (B), and SCIM score (C). Overlay of statistical parametric maps (uncorrected 
p<0.01, for illustrative purposes only) on the left side (the colour bar indicates the t-score); 
correlation with extracted mean values from the significant clusters in the right column (for 
illustrative purposes only). 
 












sex AIS Site of 
impairment 
(motor/sensory) 















1 19 13.5 M A C6/C7 C5 0 23 33 33 37 
2 24 12.2 M D T1/C6 C6 19 48 37 72 70 
3 43 15.7 M A C6/C4 C6 0 25 18 20 37 
4 72 11.9 M D T1/T2 C7 41 48 41 112 36 
5 21 12.3 M B C6/C5 C5 0 23 26 53 34 
6 31 12.3 M B T1/C7 C6 0 48 46 68 38 
7 48 12.1 M D C1/C1 none 47 35 97 98 98 
8 52 9.7 M C C7/C5 C6 12 32 44 67 31 
9 68 12.1 M D C3/C3 C4 50 50 102 107 100 
10 34 12.2 M A C7/C7 C7 0 35 29 32 26 
11 55 18.6 F D C3/C3 C4 49 42 94 62 84 
12 32 10.3 M A C6/C5 C5 0 26 20 33 30 
13 29 12.1 M A C5/C4 C4 0 14 13 16 19 
14 43 186.8 M B C6/C4 C4 0 25 32 77 29 
15 69 290.5 M D T1/C3 C4 40 49 78 69  NA 

























1 69 12.2 F D T11/T11 T6 32 49 74 92 42 
2 45 13.4 M D L3/L4 none 45 50 106 106 100 
3 53 12.0 M D T10/T10 T8 48 50 90 90 100 
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4 30 10.3 M A T10/T10 T5 16 50 78 82 80 
5 70 9.5 M A  T7/T7 T8 0 50 68 67 49 
6 72 12.0 F E intact T6 50 50 112 112 97 
7 53 54.6 M A T3/T3 T4 0 50 44 47 53 
8 36 185.5 M A T12/T12 T11 4 50 78 78 70 
9 60 68.2 M A T4/T4 T5 0 49 40 52 32 
10 53 8.0 M A T9/T9 T7 0 50 66 68 69 
11 32 10.8 M B T11/T11 T11 0 50 72 78 66 
12 29 22.8 M B T6/T6 T4 0 50 52 77 66 
13 26 10.8 M A T4/T4 T5 0 50 46 48 67 
14 39 9.3 M A T7/T7 T8 0 50 58 60 65 
15 31 12.3 M B T4/T4 T5 0 50 46 74 54 
Abbreviations: AIS: American Spinal Injury Association Impairment Scale; F: female; M: male; tSCI: patients with tetraplegia; 
pSCI: patients with paraplegia; SCIM: Spinal Cord Independence Measure 
  














mean ± sdt 
Group differences [%] p-value [95% 
Confidence 
Interval] 
cord area [mm2]      
c1 70.01 ± 8.15 62.44 ± 9.48 10.80 0.003     -12.49 to -2.65 
c2 68.88 ± 7.59 59.79 ± 10.19 13.19 <0.001     -14.13 to -4.05 
c3 68.42 ± 8.37 56.61 ± 11.64 17.26 <0.001     -17.47 to -6.13 
c4 68.58 ± 8.77 53.02 ± 15.76 22.69 <0.001     -22.25 to -8.88 
APW [mm]      
c1 8.04 ± 0.61 7.40 ± 0.71 7.96 <0.001     -0.99 to -0.29 
c2 7.74 ± 0.50 7.06 ± 0.74 8.75 <0.001     -1.04 to -0.33 
c3 7.49 ± 0.53 6.72 ± 0.88 10.28 <0.001     -1.16 to -0.39 
c4 7.32 ± 0.54 6.46 ± 0.99 11.75 <0.001     -1.30 to -0.42 
LRW [mm]      










APW: anterior posterior width; LRW: left right width; MT: magnetization transfer. 
 
c1 11.21 ± 0.74 10.89 ± 0.98 2.85 0.22 -0.83 to 0.19 
c2 11.48 ± 0.85 10.93 ± 1.00 4.79 0.03 -1.05 to -0.05 
c3 11.82 ± 0.85 10.91 ± 1.12 7.70 <0.001     -1.47 to -0.35 
c4 12.15 ± 0.90 10.78 ± 1.63 11.28 <0.001     -2.06 to -0.69 
Mean MT      
c1 3.10 ± 0.20 2.72 ± 0.29 12.26 <0.001     -0.54 to -0.23 
c2 3.13 ± 0.22 2.73 ± 0.39 12.78 <0.001     -0.57 to -0.22 
c3 3.17 ± 0.34 2.71 ± 0.44 14.51 <0.001     -0.68 to -0.23 
c4 3.14 ± 0.47 2.69 ± 0.60 14.33 <0.001     -0.72 to -0.17 
         
